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Summary 
More research suggest that parts of complete blood count might indicate disease-free and overall survival in patients 
with various cancers and therefore also in patients with head and neck cancer. Therefore, the aim of this paper was to review 
current knowledge upon signifi cance of complete blood count in head and neck cancers. PubMed was searched in the last 
10 years in order to fi nd out references upon this topic and 19 articles were included. Leukocytosis and thrombocytosis 
negatively correlate with treatment outcome in patients with head and neck cancers, however not in all studies. High 
 preoperative values of neutrophil and lymphocyte ratio suggest poorer disease outcome, i.e. shorter disease free period and 
overall survival in patients with head and neck cancer. It seems that published data provide an additional practical guide-
lines for evaluation of disease course in patients with head and neck cancer.
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ZNAČAJ RUTINSKIH KRVNIH PRETRAGA 
U BOLESNIKA S KARCINOMIMA GLAVE I VRATA
Sažetak
Sve vise je istraživanja koja pokazuju kako elementi kompletne krvne slike mogu ukazati na period bez bolesti i 
 ukupno preživljenje u bolesnika s raznim karcinomima. PubMed pregledom nađeno je 19 radova objavljenih zadnjih 10 
godina o rutinskim laboratorijskim pretragama i karcinomima glave i vrata. Leukocitoza i trombocitoza su negativno pove-
zane s ishodom liječenja u većini slučajeva bolesnika s orofaringealnim karcinomom, iako ne u svim istraživanjima. Visoke 
prijeoperacijske vrijednosti odnosa neutrofi la i limfocita ukazuju na lošiji ishod bolesti odnosno na kraći period bez bolesti 
i na lošije ukupno preživljenje u bolesnika s karcinomima glave i vrata. Čini se kako rezultati istraživanja omogućuju dodat-
ne praktične vodiče u prognostici tijeka bolesti u bolesnika koji boluju od karcinoma glave i vrata.




Current prognostic criteria in predicting out-
comes in patients with head and neck cancer are 
inadequate and easily so far available biomarkers 
are re-evaluated. Recent studies have shown that 
the presence of systemic infl ammation correlates 
with poorer disease-free and overall survival in 
patients with cancer (1,2,3). Anemia, hemoglobi-
nemia, thrombocytosis and leukocytosis are 
thought to be an adverse prognostic factors in var-
ious malignancies (1,2,3). Recently, it has been 
shown that the preoperative neutrophil/lympho-
cyte ratio (NLR) and platelet/lymphocyte ratio 
(PLR) as well as lymphocyte to monocyte ratio 
(LMR) might indicate patients which will respond 
poorly to the treatments and who have worse dis-
ease-free survival (DFS) together with overall dis-
ease survival (OS) in many cancers such as small 
cell lung carcinoma, esophageal carcinoma, pan-
creatic adenocarcinoma and head and neck can-
cers (1,2,3,4).
MATERIALS, METHODS AND RESULTS
PubMed was searched in the last 10 years in 
order to fi nd out references upon this topic. 19 ar-
ticles were included. Key words were: oral cancer, 
head and neck cancer, complete blood count, neu-
trophil/lymphocyte ratio, platelet/lymphocyte ra-
tio, lymphocyte/monocyte ratio, anemia, hemo-
globinemia, thrombocytosis, leukocytosis.
DISCUSSION
Chen et al. (4) analyzed 618 patients with oral 
cancer and found out that the incidence of leuko-
cytosis was 7.2%. Median survival of patients was 
low if the patient had leukocytosis, moreover the 
incidence of leukocytosis was high during the 
course of the disease, and had an adverse impact 
on overall survival. Therefore, the same authors 
concluded that periodic evaluation of serum white 
cell count should be performed postoperatively. 
Additionally, Peter et al. (5) followed 261 patients 
with primary squamous cell carcinoma of the oral 
cavity, pharynx, or larynx. One of the most fre-
quent laboratory pathologies was leukocytosis 
(20 %). Contrary to these results, Kruse et al. (6) 
who analyzed 278 patients with oral cancer and 
who could not report signifi cant correlation be-
tween WBC count and the development of recur-
rence or metastases. It seems that the elevated 
WBC count does not seem to be a predictor for 
recurrence or for further metastases. Tsai et al. (7) 
reported that white blood cell (WBC) count, 
monocyte, and neutrophil counts and neutrophil 
lymphocyte ratio increased with the advancement 
of clinical stage (i.e. T4) and poorer tumor diﬀ er-
entiation in patients with oral cancer, however, 
the lymphocyte count decreased. Furthermore, 
Tsai et al. reported that the higher pretreatment 
circulating monocyte count was an independent 
prognostic factor for cancer-specifi c survival in 
202 patients with oral cavity cancer and that 
monocyte count was increased in patients with 
lymph node metastasis.
Kargus et al. (8) reported that in 51 patients 
(out of 288 with head and neck cancer) who had 
recurrence, three were in the thrombocytosis 
group, and 45 patients with recurrence were in the 
normal thrombocyte range. Furthermore, Perisan-
idis et al. (9) evaluated postoperative platelet 
count changes in 102 patients with oral and oro-
pharyngeal squamous cell carcinoma and have 
shown that the failure of platelets to recover to 
normal range by the seventh postoperative day is 
an independent adverse prognostic factor in pa-
tients with oral and oropharyngeal cancer under-
going neoadjuvant treatment and surgery. Shoultz -
-Henley et al. (10) pretreatment platelet elevation 
is a promising predictor of prognosis in 433 pa-
tients with oropharyngeal cancer patients treated 
with chemo-radiation.
Grimm et al. (11) reported that NLR corre-
lated signifi cantly with PLR. LMR inversely cor-
related with NLR and PLR after analysis was per-
formed on 146 patients with OSCC. Perisanidis et 
al. (12) analyzed 97 patients with oral cancer un-
dergoing preoperative chemo-radiotherapy re-
garding DFS. The same authors (12) reported that 
a high pretreatment NLR is a signifi cant indepen-
dent predictor of shorter DFS in patients with oral 
cancer receiving preoperative chemo-radiothera-
py. Fang et al. (13) analyzed data from 226 patients 
with oral cancer and reported that elevated NLR 
was signifi cantly associated with pathological tu-
mor status, pathologic nodal metastasis, tumor 
depth, disease-free survival and overall survival. 
The infl uence NLR on disease-free survival and 
overall survival still existed after adjusting for tu-
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mor status, lymph node metastasis, and tumor cell 
diﬀ erentiation. Song et al. (14) showed that high 
preoperative NLR is associated with increased 
wound complications and poor survival in pa-
tients with hypopharyngeal squamous cell carci-
noma after radical resections.
Rassouli et al. (15) concluded that PLR is an 
independent predictor of mortality, NLR is an in-
dependent predictor of recurrence in 273 head 
and neck cancer patients. Huang et al. (16) report-
ed that high circulating neutrophil count and 
monocyte count predict worse overall and recur-
rence-free survival, while high circulating lym-
phocyte count predicts bett er recurrence-free sur-
vival and marginally bett er overall survival in 
these patients who are HPV positive. However, 
this association was not apparent in HPV-negative 
patients. He et al. (17) concluded that pretreat-
ment NLR and percentages of neutrophil and 
lymphocytes were independent prognostic vari-
ables of survival in 1410 patients with nasopha-
ryngeal carcinoma. Jin et al. (18) found out that 
pretreatment NLR was a signifi cant prognostic 
variable of poor prognosis in 229 patients with 
metastatic nasopharyngeal carcinoma. Jiang et al. 
(19) identifi ed that pretreatment LMR was an in-
dependent prognostic factor for 672 patients with 
metastatic nasopharyngeal carcinoma.
Grimm et al. (20) analyzed 187 patients with 
OSCC. CRP levels, Hb levels, and WBC count and 
showed signifi cant diﬀ erences between non-re-
current and recurrent group of OSCC. On univari-
ate analysis, patients with high pre-treatment LPI 
(LPI ≥ 2) had a signifi cant poorer prognosis. Mul-
tivariate analysis showed that the most important 
independent prognostic factor was high pre-treat-
ment LPI (LPI ≥ 2). Moreover, pre-treatment LPI ≥ 
2 showed high probability that loco-regional re-
currence will be present later. The same study (20) 
highlights the combination of infl ammatory CRP 
levels, Hb levels, and WBC count as the most im-
portant independent prognostic factor in predict-
ing disease recurrence of patients with OSCC. LPI 
can be used as a pre-treatment infl ammatory bio-
marker that may identify OSCC with a more ag-
gressive biological phenotype of the disease and 
might be helpful for guiding further post-opera-
tive treatment in OSCC.
Rachidi et al. (21) reported that NLR is a ro-
bust predictor of overall survival in oral, pharyn-
geal, and laryngeal squamous cell carcinomas 
Fang et al. (22) analyzed data from 226 patients 
with oral cancer and reported that elevated NLR 
was signifi cantly associated with tumor status, 
nodal metastasis, tumor depth, disease-free sur-
vival and overall survival. The level of NLR on 
DFS and OS has been shown to exist still after ad-
justing data for tumor status, lymph node metas-
tasis, and tumor cell diﬀ erentiation.
CONCLUSION
It seems that this data provides an additional 
practical guideline of further postoperative man-
agement patients with head and neck cancer.
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